Company News in the Life Science Industry

»

Reset 

Avelas Biosciences' AVB-620 Shows Sensitive In Vivo Visualization of Breast Cancer in Journal Publication

SAN DIEGO, Sept. 14, 2017 /PRNewswire/ -- Avelas Biosciences, Inc., a clinical stage oncology-focused company dedicated to improving cancer patient care from diagnosis through treatment, today announced the publication of a paper in the scientific journal Theranostics showing that AVB-620... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Avelas Biosciences, Inc.

Plant geneticists develop a new application of CRISPR to break yield barriers in crops

COLD SPRING HARBOR, N.Y., Sept. 14, 2017 /PRNewswire/ -- Scientists at Cold Spring Harbor Laboratory (CSHL) have harnessed the still untapped power of genome editing to improve agricultural crops. Using tomato as an example, they have mobilized CRISPR/Cas9 technology to rapidly generate variants... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017

Eton Pharmaceuticals Appoints Paul V. Maier to its Board of Directors

DEER PARK, Ill., Sept. 14, 2017 /PRNewswire/ -- Eton Pharmaceuticals, Inc. today announced it has appointed Paul V. Maier to its Board of Directors.

Read more ››
By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Eton Bioscience, Inc. | Eton Bioscience | Eton Pharmaceuticals, Inc.

Biosimilars Forum Opposes Current CMS Rule That Would Adversely Affect Biosimilars Development in the U.S.; Submits Comments on Appropriate Biosimilar Reimbursement Policy

WASHINGTON, Sept. 14, 2017 /PRNewswire/ -- Recently, the Biosimilars Forum submitted comments on the Centers for Medicare & Medicaid Services' (CMS) proposed Medicare Physician Fee Schedule (MPFS) regarding biosimilar reimbursement policy that was finalized in 2016.

Read more ››
By: PR Newswire Association LLC. - 14 Sep 2017

SimplyVital Health Invited to Inaugural MDP Labs Program

BLOOMFIELD, Conn., Sept. 14, 2017 /PRNewswire/ -- SimplyVital Health (SVH), the healthcare company using blockchain technology to tackle bundled payments, has been accepted into athenahealth's inaugural More Disruption Please (MDP) Labs program. SVH is one of just 10 companies selected from over... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  athenahealth, Inc.

FDA Approves Amgen And Allergan's MVASI(TM) (bevacizumab-awwb) For The Treatment Of Five Types Of Cancer

THOUSAND OAKS, Calif., Sept. 14, 2017 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and Allergan plc. (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved MVASI(TM) (bevacizumab-awwb) for all eligible indications of the reference product, Avastin(®) (bevacizumab).... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Amgen, Inc.

ZEISS Unveils Ultra-Widefield Fundus Imaging Technology in U.S.

DUBLIN, Calif. and LAS VEGAS, Sept. 14, 2017 /PRNewswire/ -- ZEISS CLARUS((TM)) 500 Ultra-widefield system leverages legendary ZEISS precision optics to provide high resolution retinal imaging across the entire retina. CLARUS 500 is the first fundus imaging system combining true color and... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017

Wildflower Enjoys Beneficial Weight Management, Sports Nutrition & Vitamin EPPS

BOCA RATON, Fla., Sept. 14, 2017 /PRNewswire/ -- Wildflower, a company offering cannabis-based nutritional products for general wellness applications, successfully participated in the recent Weight Management, Sports Nutrition and Vitamin Efficient Planning Program Session (EPPS).

Read more ››
By: PR Newswire Association LLC. - 14 Sep 2017

Through Special Initiative, NYU Langone Hospital - Brooklyn Improves Healthcare Delivery and Outcomes

BROOKLYN, Sept. 14, 2017 /PRNewswire-USNewswire/ -- NYU Langone Hospital - Brooklyn is making tremendous strides to provide high-quality healthcare--with measurable outcomes--to the borough's underserved populations.

Read more ››
By: PR Newswire Association LLC. - 14 Sep 2017

/DISREGARD RELEASE: Pear Therapeutics/

Journalists and other readers should disregard the news release, Pear Therapeutics Obtains FDA Clearance of the First Prescription Digital Therapeutic to Treat Disease, issued 14-Sep-2017. An incorrect version was released by PR Newswire inadvertently.

Read more ››
By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Pear Therapeutics, Inc.

New Gustavus Adolphus College Study Reveals:  Majority of U.S. Men Say They'd Be Likely to Take Pill or Injection as Male Birth Control, But Many Express Concern Over How They Would Be Perceived by Women

MINNEAPOLIS, Sept. 14, 2017 /PRNewswire/ -- A majority of men (65%) say they'd be likely to take a hormone pill or injection as a means of birth control if they were in a committed, long-term relationship. What's more, 57% of men say they'd be likely to do the same if they were in a short-term... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017

Efficacy of Philips' Stellarex .035" low-dose drug-coated balloon demonstrated in clinical trial at two years

- Two-year data from the ILLUMENATE European randomized clinical trial (EU RCT) validates durable clinical performance of Stellarex low-dose drug-coated balloon

Read more ››
By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Philips Respironics

Janssen Submits Supplemental New Drug Application to U.S. FDA for ZYTIGA® (abiraterone acetate) to Treat Men with Earlier Stages of Metastatic Prostate Cancer

HORSHAM, Pa., Sept. 14, 2017 /PRNewswire/ -- Janssen Biotech, Inc. today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking to expand the indication of ZYTIGA(®) in combination with prednisone and ADT to include treatment... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Janssen Biotech, Inc. | Janssen Research & Development, LLC | Janssen Research & Development, LLC

Achieve Announces Share Purchase Agreement with Lincoln Park Capital Fund, LLC

BOTHELL, Wash. and VANCOUVER, British Columbia, Sept. 14, 2017 /CNW/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced that it has entered into a share... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Achieve Life Sciences Inc.

FDA Not Currently Planning to Hold Advisory Committee Meeting for BioMarin's Pegvaliase Biologics License Application (BLA)

SAN RAFAEL, Calif., Sept. 14, 2017 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the U.S. Food and Drug Administration (FDA) has provided the company with the "Day-74" filing communication for its Biologics License Application (BLA) for pegvaliase, a PEGylated... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  BioMarin Pharmaceutical Inc.

Gexa Energy Offers Houston Single Mom with Blood Cancer One Full Year of Free Electricity

RYE BROOK, N.Y., Sept. 14, 2017 /PRNewswire-USNewswire/ -- When you or someone you love hears the words, "you have cancer," it's a very dark moment. Today, Gexa Energy, a leading Texas electricity provider based in Houston,... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  The Leukemia & Lymphoma Society

Bodycad Announces First Use of Its Unicompartmental Knee System in Patients

QUEBEC CITY, Sept. 14, 2017 /PRNewswire/ -- Bodycad has announced that the first personalized restoration procedures using its Unicompartmental Knee System in patients have been successfully performed.

Read more ››
By: PR Newswire Association LLC. - 14 Sep 2017

Bavarian Nordic to Host Capital Markets Day in New York City

Read more ››
By: Nasdaq / GlobenewsWire - 14 Sep 2017
Related companies:  Bavarian Nordic A/S | Bavarian Nordic GmbH

Targovax Receives 2017 Nordic Stars Award

Read more ››
By: Nasdaq / GlobenewsWire - 14 Sep 2017
Related companies:  Targovax ASA

Medtronic Announces Inaugural 2017 Global Champions Team

Read more ››
By: Nasdaq / GlobenewsWire - 14 Sep 2017
Related companies:  Medtronic Plc
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20 21  22  23  24  25 »

Explore our database of over 40,000 companies